BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
+$467M |
| 2 |
Alibaba
BABA
|
+$273M |
| 3 |
Citigroup
C
|
+$263M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
+$123M |
| 5 |
Ambev
ABEV
|
+$93.4M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.35B |
| 2 |
Apple
AAPL
|
+$300M |
| 3 |
Bank of America
BAC
|
+$272M |
| 4 |
Microsoft
MSFT
|
+$252M |
| 5 |
Amazon
AMZN
|
+$235M |
Sector Composition
| 1 | Financials | 12.19% |
| 2 | Technology | 11.6% |
| 3 | Healthcare | 10.11% |
| 4 | Communication Services | 9.76% |
| 5 | Consumer Discretionary | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Intrepid Potash
IPI
$389M
| $38.3K | ﹤0.01% |
1,694
+1,224
| +260% | +$27.7K |
|
2777
First Mid Bancshares
FMBH
$945M
| $38.3K | ﹤0.01% |
1,118
+1,042
| +1,371% | +$35.7K |
|
2778
Global Indemnity Group
GBLI
$428M
| $38.2K | ﹤0.01% |
984
+925
| +1,568% | +$35.9K |
|
|
MGP
2779
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $38.1K | ﹤0.01% |
1,306
-1,395
| -52% | -$40.7K |
|
2780
CNB Financial Corp
CCNE
$761M
| $38.1K | ﹤0.01% |
1,590
+1,505
| +1,771% | +$36.1K |
|
2781
MidWestOne Financial Group
MOFG
$604M
| $38.1K | ﹤0.01% |
1,124
+1,106
| +6,144% | +$37.5K |
|
|
IIP
2782
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
| $38.1K | ﹤0.01% |
10,376
+8,571
| +475% | +$31.5K |
|
2783
Old Second Bancorp
OSBC
$961M
| $38K | ﹤0.01% |
3,292
+3,057
| +1,301% | +$35.3K |
|
2784
Farmers National Banc Corp
FMNB
$554M
| $38K | ﹤0.01% |
2,621
+2,534
| +2,913% | +$36.7K |
|
2785
iShares MSCI Malaysia ETF
EWM
$245M
| $37.9K | ﹤0.01% |
1,196
| – | – |
|
2786
Novavax
NVAX
$1.3B
| $37.9K | ﹤0.01% |
1,647
+1,327
| +415% | +$30.5K |
|
|
GPX
2787
DELISTED
GP Strategies Corp.
GPX
| $37.7K | ﹤0.01% |
1,429
+1,384
| +3,076% | +$36.5K |
|
|
TVRD
2788
Tvardi Therapeutics, Inc. Common Stock
TVRD
$318M
| $37.7K | ﹤0.01% |
68
+67
| +6,700% | +$37.2K |
|
2789
Peoples Financial Services
PFIS
$525M
| $37.6K | ﹤0.01% |
859
+731
| +571% | +$32K |
|
|
BBOX
2790
DELISTED
Black Box Corp
BBOX
| $37.5K | ﹤0.01% |
4,388
-565
| -11% | -$4.83K |
|
2791
Winmark
WINA
$1.74B
| $37.4K | ﹤0.01% |
290
+267
| +1,161% | +$34.4K |
|
2792
Hackett Group
HCKT
$575M
| $37.4K | ﹤0.01% |
2,411
+2,320
| +2,549% | +$36K |
|
2793
MasterCraft Boat Holdings
MCFT
$362M
| $37.3K | ﹤0.01% |
1,910
+1,831
| +2,318% | +$35.8K |
|
|
CYOU
2794
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $37.3K | ﹤0.01% |
+962
| New | +$37.3K |
|
2795
Natera
NTRA
$23.1B
| $37.3K | ﹤0.01% |
3,431
+2,888
| +532% | +$31.4K |
|
2796
VSE Corp
VSEC
$3.4B
| $37K | ﹤0.01% |
823
+809
| +5,779% | +$36.4K |
|
|
HABT
2797
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $37K | ﹤0.01% |
2,339
+2,031
| +659% | +$32.1K |
|
2798
Tejon Ranch
TRC
$448M
| $36.9K | ﹤0.01% |
1,841
+1,539
| +510% | +$30.8K |
|
2799
Calix
CALX
$4.01B
| $36.8K | ﹤0.01% |
5,369
+4,436
| +475% | +$30.4K |
|
2800
Atara Biotherapeutics
ATRA
$85.1M
| $36.4K | ﹤0.01% |
104
+99
| +1,980% | +$34.7K |
|